Schedule 13D ownership disclosure
Silence Therapeutics plc
Ordinary Shares, nominal value of GBP0.05 per share · CUSIP: G8128Y157
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Richard Ian GriffithsReported CIK 0001846370
Shares: 29,283,897.00 · Class: 20.7%
- Ora Capital Limited
Shares: 19,221,525.00 · Class: 13.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-029716
- Form type
- SCHEDULE 13D/A
- Filer
- Griffiths Richard Ian
- CIK
- CIK 1846370
- Filed
- Mar 31, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13D beneficial ownership